Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiviral drugs are used to treat viral infections such as human immunodeficiency virus (HIV), hepatitis, and influenza. Several investigational drugs are currently being developed for the treatment of HIV infection.
North America accounts for the majority of the market share due to the presence of major market players, advanced medical infrastructure, and increased awareness of viral diseases. The global antiviral drugs market size is expected to register a CAGR of -2.2% over the forecast period, 2020-2026.
The prevalence of viral infections such as HIV, hepatitis, respiratory syncytial virus (RSV), and influenza will drive the demand for antiviral drugs. However, increased precautions and awareness of vaccines for viral infections will limit the growth of the antiviral market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antiviral Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antiviral Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antiviral Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Roche
Merck
Bristol-Myers Squibb
AbbVie
Novartis
By Type:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
By End-User:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antiviral Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antiviral Drugs Market Size and Growth Rate of Reverse Transcriptase Inhibitors from 2016 to 2027
-
1.3.2 USA Antiviral Drugs Market Size and Growth Rate of Protease Inhibitors from 2016 to 2027
-
1.3.3 USA Antiviral Drugs Market Size and Growth Rate of Fusion Inhibitors from 2016 to 2027
-
1.3.4 USA Antiviral Drugs Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antiviral Drugs Market Size and Growth Rate of Hepatitis Therapeutics from 2016 to 2027
-
1.4.2 USA Antiviral Drugs Market Size and Growth Rate of HIV/AIDS Therapeutics from 2016 to 2027
-
1.4.3 USA Antiviral Drugs Market Size and Growth Rate of Herpes Therapeutics from 2016 to 2027
-
1.4.4 USA Antiviral Drugs Market Size and Growth Rate of Influenza Therapeutics from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antiviral Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antiviral Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Reverse Transcriptase Inhibitors
-
3.4.2 Market Size and Growth Rate of Protease Inhibitors
-
3.4.3 Market Size and Growth Rate of Fusion Inhibitors
-
3.4.4 Market Size and Growth Rate of Immune System Modulators
4 Segmentation of Antiviral Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antiviral Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antiviral Drugs in Hepatitis Therapeutics
-
4.4.2 Market Size and Growth Rate of Antiviral Drugs in HIV/AIDS Therapeutics
-
4.4.3 Market Size and Growth Rate of Antiviral Drugs in Herpes Therapeutics
-
4.4.4 Market Size and Growth Rate of Antiviral Drugs in Influenza Therapeutics
5 Market Analysis by Regions
-
5.1 USA Antiviral Drugs Production Analysis by Regions
-
5.2 USA Antiviral Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antiviral Drugs Landscape Analysis
-
6.1 West USA Antiviral Drugs Landscape Analysis by Major Types
-
6.2 West USA Antiviral Drugs Landscape Analysis by Major End-Users
7 South USA Antiviral Drugs Landscape Analysis
-
7.1 South USA Antiviral Drugs Landscape Analysis by Major Types
-
7.2 South USA Antiviral Drugs Landscape Analysis by Major End-Users
8 Middle West USA Antiviral Drugs Landscape Analysis
-
8.1 Middle West USA Antiviral Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Antiviral Drugs Landscape Analysis by Major End-Users
9 Northeast USA Antiviral Drugs Landscape Analysis
-
9.1 Northeast USA Antiviral Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Antiviral Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Gilead Sciences
-
10.1.1 Gilead Sciences Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 GlaxoSmithKline
-
10.2.1 GlaxoSmithKline Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Johnson & Johnson
-
10.3.1 Johnson & Johnson Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche
-
10.4.1 Roche Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Merck
-
10.5.1 Merck Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bristol-Myers Squibb
-
10.6.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 AbbVie
-
10.7.1 AbbVie Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Novartis
-
10.8.1 Novartis Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Reverse Transcriptase Inhibitors from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Protease Inhibitors from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Fusion Inhibitors from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Hepatitis Therapeutics from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of HIV/AIDS Therapeutics from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Herpes Therapeutics from 2016 to 2027
-
Figure USA Antiviral Drugs Market Size and Growth Rate of Influenza Therapeutics from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antiviral Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antiviral Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antiviral Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Antiviral Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Reverse Transcriptase Inhibitors
-
Figure Market Size and Growth Rate of Protease Inhibitors
-
Figure Market Size and Growth Rate of Fusion Inhibitors
-
Figure Market Size and Growth Rate of Immune System Modulators
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antiviral Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antiviral Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hepatitis Therapeutics
-
Figure Market Size and Growth Rate of HIV/AIDS Therapeutics
-
Figure Market Size and Growth Rate of Herpes Therapeutics
-
Figure Market Size and Growth Rate of Influenza Therapeutics
-
Table USA Antiviral Drugs Production by Regions
-
Table USA Antiviral Drugs Production Share by Regions
-
Figure USA Antiviral Drugs Production Share by Regions in 2016
-
Figure USA Antiviral Drugs Production Share by Regions in 2021
-
Figure USA Antiviral Drugs Production Share by Regions in 2027
-
Table USA Antiviral Drugs Consumption by Regions
-
Table USA Antiviral Drugs Consumption Share by Regions
-
Figure USA Antiviral Drugs Consumption Share by Regions in 2016
-
Figure USA Antiviral Drugs Consumption Share by Regions in 2021
-
Figure USA Antiviral Drugs Consumption Share by Regions in 2027
-
Table West USA Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table West USA Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Antiviral Drugs Consumption Share by Types in 2016
-
Figure West USA Antiviral Drugs Consumption Share by Types in 2021
-
Figure West USA Antiviral Drugs Consumption Share by Types in 2027
-
Table West USA Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure West USA Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure West USA Antiviral Drugs Consumption Share by End-Users in 2027
-
Table South USA Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table South USA Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Antiviral Drugs Consumption Share by Types in 2016
-
Figure South USA Antiviral Drugs Consumption Share by Types in 2021
-
Figure South USA Antiviral Drugs Consumption Share by Types in 2027
-
Table South USA Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure South USA Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure South USA Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antiviral Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Antiviral Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Antiviral Drugs Consumption Share by Types in 2027
-
Table Middle West USA Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antiviral Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Antiviral Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Antiviral Drugs Consumption Share by Types in 2027
-
Table Northeast USA Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
